Ottawa, Ontario – The National Mental Health Association reports that over 65 million Americans suffer from some type of mental illness. By 2020, mental illness is projected to be the leading cause of the disease burden in North America. That obviously is a problem of staggering magnitude, with total costs to society in the hundreds of billions every year. Northam Psychotechnologies, an Ottawa, Ontario-based company holds the North American patent pending to futuristic technologies that provide a profoundly powerful solution to this problem.
Semantic Stimuli Response Measurement (SSRM) is a powerful psychological screening tool. It is the world’s first technology designed and utilized to meticulously measure the response of the subconscious mind outside of a laboratory setting. Internationally renowned brain researcher, Dr. Semyon Ioffe, has adapted this technology, which is the direct result of a worldwide body of scientific knowledge, to accommodate the North American conglomerate. He states, “We are the first testing and teaching Technology Company in the areas of Mental Health, and are able to effectively test for and detect early stages of mental disorders. We also test the effectiveness of medical or psychological treatment for mental disorders, and teach patients, on a subconscious level, to free themselves from drug and alcohol addictions, phobias, suicidal tendencies, PTSD and so much more.”
SSRM Tek can effectively enhance treatment accuracy and efficacy by determining the root causes of mental afflictions. Treatment times are significantly reduced. The necessity of follow-up procedures is diminished greatly. Unnecessary treatment methods are eliminated. And the results generated are virtually error-free. “SSRM Tek easily obtains invaluable information from a source that never lies: the subconscious mind.” Dr. Ioffe states further, “This technology has been in development for over five decades. It has surfaced strongly now and is the future of mental health care standards.”
SSRM Tek can determine the effectiveness of the treatment being provided to patients. Concurrent testing and re-testing can determine if the treatment is having positive effects on the patient and is able to follow up on the progress of the treatment. As the world’s first technology to measure the response of the subconscious mind outside a laboratory setting, this precise psychological screening tool can be used broadly in a multitude of fashions. Dr. Ioffe concludes, “We want everyone to feel very confident in requesting more information about SSRM Tek and encourage them to do so freely.”
About Northam Psychotechnologies: Ottawa-based Northam Psychotechnologies is an integrated solutions provider that utilizes SSRM Tek as the key tool to provide solutions for mental health issues. It is a registered Canadian company with shareholders. Northam Psychotechnologies, which holds both the US and Canadian patents pending, is owned by Dr. Semyon Ioffe. Dr. Ioffe, an internationally renowned brain researcher, is widely published and esteemed. A strong band of experts complement the SSRM Tek team, which is fully committed to helping keep North Americans safe and healthy.
Northam Psychotechnologies | Detection | Identification | Treatment
